- Home
- NNN vs ROIV Comparison
NNN vs ROIV Comparison
Compare NNN & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNN
- ROIV
- Stock Information
- Founded
- NNN 1984
- ROIV 2014
- Country
- NNN United States
- ROIV United Kingdom
- Employees
- NNN N/A
- ROIV N/A
- Industry
- NNN Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- NNN Real Estate
- ROIV Health Care
- Exchange
- NNN Nasdaq
- ROIV Nasdaq
- Market Cap
- NNN 7.8B
- ROIV 8.6B
- IPO Year
- NNN N/A
- ROIV N/A
- Fundamental
- Price
- NNN $42.58
- ROIV $15.28
- Analyst Decision
- NNN Hold
- ROIV Strong Buy
- Analyst Count
- NNN 8
- ROIV 4
- Target Price
- NNN $44.14
- ROIV $15.50
- AVG Volume (30 Days)
- NNN 1.2M
- ROIV 7.8M
- Earning Date
- NNN 10-30-2025
- ROIV 11-11-2025
- Dividend Yield
- NNN 5.63%
- ROIV N/A
- EPS Growth
- NNN N/A
- ROIV N/A
- EPS
- NNN 2.10
- ROIV N/A
- Revenue
- NNN $894,702,000.00
- ROIV $23,233,000.00
- Revenue This Year
- NNN $5.26
- ROIV N/A
- Revenue Next Year
- NNN $4.00
- ROIV $281.14
- P/E Ratio
- NNN $20.30
- ROIV N/A
- Revenue Growth
- NNN 4.82
- ROIV N/A
- 52 Week Low
- NNN $35.80
- ROIV $8.73
- 52 Week High
- NNN $49.57
- ROIV $16.05
- Technical
- Relative Strength Index (RSI)
- NNN 50.69
- ROIV 82.00
- Support Level
- NNN $42.36
- ROIV $13.81
- Resistance Level
- NNN $43.35
- ROIV $14.48
- Average True Range (ATR)
- NNN 0.60
- ROIV 0.47
- MACD
- NNN 0.01
- ROIV 0.22
- Stochastic Oscillator
- NNN 49.67
- ROIV 81.67
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.